Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants

Clinical trial NCT00969228 · COMPLETED

Trial details

NCT number: NCT00969228
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Infections, Rotavirus Rotavirus Vaccines

Start date: 2009-08-25
Primary completion: 2010-07-23
Enrollment: 684

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.